EquityFlowCompanies › Cykinso

Cykinso

Healthtech · Tokyo, JP · cykinso.co.jp

Gestisce Mykinso, test domestico del microbiota intestinale con soluzioni personalizzate di prevenzione.

Funding history

DateRoundAmount
Apr 2026Series D Plus
Cykinso completed its Series D with a second close of the extension round (amount undisclosed) subscribed by Inno Associates and regional funds.
Aug 2024Series D Plus
Cykinso, which runs the Mykinso gut-microbiome test, raised a Series D extension from Nittobo, Nihonkai Lab and Fuji Nihon Seito, taking the Series D total to about 1.15B JPY and cumulative funding to about 2.65B JPY.
$2.3M
Jul 2023Series D Plus
Gut-microbiome testing company Cykinso (Mykinso) raised JPY 800M in a Series D; cumulative funding reached about JPY 2.3B.
$5.5M

Investors

Akigin Capital PartnersFuji Nihon SeitoGreen Next CreateInno AssociatesNOBUNAGA Capital VillageNihonkai LabNittoboYamanashi Chugin Management Consulting

Similar companies in Healthtech

Explore funding flow on EquityFlow →